Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News PetVivo Holdings Inc PETV

PetVivo Holdings, Inc. is a biomedical device company, which is focused on the manufacturing, commercialization and licensing of medical devices and therapeutics for animals. The Company's lead product Spryng with OsteoCushion technology, is a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses... see more

Recent & Breaking News (OTCPK:PETV)

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN INDIANAPOLIS, INDIANA

GlobeNewswire 10 days ago

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN NAPLES FLORIDA

GlobeNewswire April 3, 2024

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN CHARLESTON, SOUTH CAROLINA

GlobeNewswire April 3, 2024

SmallCapVoice.com Inc. ("SCV") to Host First Annual Safety Summit featuring Up-and-Coming Public Companies

GlobeNewswire March 14, 2024

Garry Lowenthal Joins PetVivo Holdings, Inc. as the Chief Financial Officer

GlobeNewswire March 11, 2024

PetVivo Holdings, Inc. Commences Trading on Upstream Under PETV

GlobeNewswire March 5, 2024

Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Lake Tahoe, California

GlobeNewswire February 29, 2024

PetVivo Holdings, Inc. Approved to Dual List on Upstream

GlobeNewswire February 27, 2024

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN VETERINARY CONFERENCE IN LAS VEGAS, NEVADA

GlobeNewswire February 13, 2024

PetVivo Reports Third Quarter of Fiscal 2024 Financial Results

GlobeNewswire February 12, 2024

PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng(TM) with OsteoCushion(TM) Technolgoy

GlobeNewswire February 7, 2024

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024

GlobeNewswire February 6, 2024

PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-articular Injections of Spryng(TM) with OsteoCushion(TM) Technology

GlobeNewswire January 31, 2024

PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent Application

GlobeNewswire January 23, 2024

PetVivo Holdings, Inc. Invites You to Join Us at The Microcap Conference

Newsfile January 11, 2024

PETVIVO HOLDINGS, INC. TO EXHIBIT AT VETERINARY MEETING AND EXPO CONFERENCE IN ORLANDO, FLORIDA

GlobeNewswire January 9, 2024

PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH COVETRUS NORTH AMERICA, LLC

GlobeNewswire December 22, 2023

PetVivo Holdings, Inc. Achieves Distribution Milestone Surpassing 4500 Syringes of Spryng(TM) in 2023

GlobeNewswire December 21, 2023

PetVivo Holdings, Inc. Achieves National Distribution of Spryng(TM) to More than 600 Veterinary Clinics in 49 States

GlobeNewswire December 11, 2023

PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in San Diego, California

GlobeNewswire November 21, 2023